Company Monitoring Page for Novartis

latest headlines for company on cafepharma

How Far Into the Drug Pipeline Should the FTC Reach?
TheStreet.com
Mon, 05/1/17 - 10:59 am
Tags:
FTC, GSK, Novartis, BRAF inhibitor, MEK inhibitor, melanoma, Array Biopharma, M&A
5 Big Drugmakers With Important Catalysts in May
Motley Fool
Sun, 04/30/17 - 01:00 pm
Tags:
FDA, Merck, Keytruda, Isentress, Novartis, PKC412, Novo Nordisk, nonacog beta pegol, Sanofi, Regeneron, Kevzara
Novartis bags FDA OK for Rydapt, adding a new chemo combo drug for AML
Endpoints
Sat, 04/29/17 - 10:02 am
Tags:
Novartis, FDA, Rydapt, chemotherapy, AML, acute myeloid leukemia
Novartis slapped with $49m fine over kickbacks
Drug Delivery Business News
Fri, 04/28/17 - 11:46 am
Tags:
Novartis, kickbacks, South Korea, Exelon
1Q17 Earnings for Novartis’s Alcon, Its Eye Care Business
Market Realist
Fri, 04/28/17 - 11:42 am
Tags:
Novartis, earnings, Alcon, eye care, eye health
Novartis looks earlier as biotech gets too expensive
BioPharma Dive
Tue, 04/25/17 - 11:27 pm
Tags:
Novartis, M&A, earnings
Novartis beats 1Q profit forecasts
Yahoo/AP
Tue, 04/25/17 - 11:31 am
Tags:
Novartis, earnings
With late-stage data in on the CGRP migraine drug erenumab, Novartis and Amgen rework commercialization pact
Endpoints
Tue, 04/25/17 - 11:03 am
Tags:
Novartis, Amgen, CGRP blockers, migraines, erenumab
J&J, Takeda among interested in Brazil's Hypermarcas, sources say
Yahoo/Reuters
Mon, 04/24/17 - 10:04 pm
Tags:
JNJ, Takeda, Hypermarcas, Brazil, M&A, Novartis
Novartis’s 1Q17 Estimates for Alcon
Market Realist
Mon, 04/24/17 - 10:17 am
Tags:
Novartis, Alcon, earnings, eye health
Novartis’s 1Q17 Estimates: Innovative Medicines Segment
Market Realist
Sun, 04/23/17 - 09:58 am
Tags:
Novartis, earnings
Analysts Expect Novartis’s Revenues to Remain Flat in 1Q17
Market Realist
Sat, 04/22/17 - 01:21 pm
Tags:
Novartis, earnings
Novartis Tests New Alzheimer's Drugs on People Who Don't Have the Disease
FOX Business
Sat, 04/22/17 - 01:12 pm
Tags:
Novartis, Alzheimer's disease
Black box warning? No worries, Valeant bills Siliq as the ‘low-cost’ psoriasis alternative to rivals from Novartis, Eli Lilly
Endpoints
Fri, 04/21/17 - 11:45 am
Tags:
Valeant Pharmaceuticals, Siliq, black box, Eli Lilly, Novartis, psoriasis
China pharma poised for explosive growth, Novartis CEO says
Fierce Pharma
Wed, 04/19/17 - 04:16 pm
Tags:
China, Novartis, Pharma CEOs, Joe Jimenez
Allergan, Novartis ink NASH partnership
BioPharma Dive
Wed, 04/19/17 - 10:02 am
Tags:
Allergan, Novartis, NASH, Cenicriviroc, LJN452
Hey Pfizer, Novartis and Eli Lilly. G1 Therapeutics says it can beat all of you in its $115M IPO
Endpoints
Tue, 04/18/17 - 08:58 pm
Tags:
G1 Therapeutics, IPOs, Pfizer, Novartis, Eli Lilly, cancer, R&D
Novartis Snags Coveted FDA 'Breakthrough' Label for CAR-T, Trial Results Still Under Wraps
TheStreet.com
Tue, 04/18/17 - 09:49 am
Tags:
Novartis, Kite Pharma, FDA, CAR-T, breakthrough status, CTL019
When do pharmas disclose launch prices up front? When they’re pricing at a discount
Fierce Pharma
Fri, 04/14/17 - 10:03 am
Tags:
drug discounts, drug pricing, Roche, Neurocrine, Sanofi, Regeneron, Tesaro, Novartis
Novartis' Gilenya patent loss sets MS market up for battle with early generics
Fierce Pharma
Thu, 04/13/17 - 06:49 pm
Tags:
Novartis, Gilenya, MS, multiple sclerosis, generics

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.